NL293572A
(en)
|
1962-06-07 |
|
|
|
CH499528A
(en)
|
1965-10-22 |
1970-11-30 |
Ciba Geigy Ag |
N,n'-di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanes - with antiprotozoal activity
|
CH480410A
(en)
|
1967-01-09 |
1969-10-31 |
Geigy Ag J R |
Process for the preparation of water-soluble azopyrimidine dyes
|
CA961052A
(en)
|
1967-01-12 |
1975-01-14 |
Max Schellenbaum |
N-2-ethylhexyl-n'-aryl ureas and preparation containing them
|
US3608087A
(en)
|
1968-06-21 |
1971-09-21 |
Merck & Co Inc |
Feed compositions
|
US3887329A
(en)
|
1969-05-05 |
1975-06-03 |
Ciba Geigy Ag |
Hexamethyl phosphotriamide-dye compositions
|
US3686238A
(en)
|
1970-01-19 |
1972-08-22 |
Syntex Corp |
Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
|
US3852434A
(en)
|
1970-09-11 |
1974-12-03 |
Merck & Co Inc |
Potentiation of ({31 ) cis-1,2-epoxypropyl)phosphonic acid and analogues thereof
|
US3690834A
(en)
|
1971-01-11 |
1972-09-12 |
Syva Co |
Ligand determination with spin labeled compounds by receptor displacement
|
US3966744A
(en)
|
1971-01-11 |
1976-06-29 |
Syva Company |
Spin labeled compounds
|
DE2106585A1
(en)
|
1971-02-11 |
1972-08-24 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Aminothiodiazoles and thiodiazole azo dyes
|
DE2226703A1
(en)
|
1972-05-25 |
1973-12-13 |
Schering Ag |
NEW TETRAHYDROCARBAZOLE DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION
|
US3966764A
(en)
|
1972-07-10 |
1976-06-29 |
Syva Company |
Ligand determination of spin labeled compounds by receptor displacement-amphetamine analogs
|
US3849420A
(en)
|
1972-10-20 |
1974-11-19 |
Dow Chemical Co |
Bis-(alkylthio-and alkylsulfonyl)-pentachloroquinolines
|
CH574206A5
(en)
|
1972-11-16 |
1976-04-15 |
Ciba Geigy Ag |
|
DE2340569C2
(en)
|
1973-08-10 |
1982-12-02 |
Bayer Ag, 5090 Leverkusen |
Azo dyes
|
AT340933B
(en)
|
1973-08-20 |
1978-01-10 |
Thomae Gmbh Dr K |
PROCESS FOR THE PRODUCTION OF NEW PYRIMIDE DERIVATIVES AND THEIR ACID ADDITIONAL SALTS
|
US4057559A
(en)
|
1973-10-01 |
1977-11-08 |
American Home Products Corporation |
Carbazole acetic acid derivatives
|
US4101541A
(en)
|
1973-12-21 |
1978-07-18 |
Ciba-Geigy Corporation |
3-Cyano-1,2,4-thiadiazolyl-5-czo dyestuffs
|
FR2306697A1
(en)
|
1975-04-10 |
1976-11-05 |
Sogeras |
NEW PYRIMIDINES FOR USE AS ANTIDIABETIC AND HYPOCHOLESTEROLEMANT MEDICINAL PRODUCTS
|
US4189579A
(en)
|
1977-05-20 |
1980-02-19 |
The Dow Chemical Company |
Aminoalkylthiopurines
|
US4139705A
(en)
|
1977-05-20 |
1979-02-13 |
The Dow Chemical Company |
Pyrazolopyrimidines
|
DE2731264A1
(en)
|
1977-07-11 |
1979-02-01 |
Boehringer Mannheim Gmbh |
NEW 1-ACYL-2-CYANAZIRIDINE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
|
JPS6038696B2
(en)
|
1977-12-09 |
1985-09-02 |
コニカ株式会社 |
Silver halide color photographic material
|
US4242507A
(en)
|
1978-02-23 |
1980-12-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Sulfonic acid esters
|
DE2831580C2
(en)
|
1978-07-18 |
1980-09-18 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Method and reagent for the determination of glycerin
|
DE2906603A1
(en)
|
1979-02-21 |
1980-09-04 |
Boehringer Mannheim Gmbh |
N-SUBSTITUTED AZIRIDINE-2-CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
|
US4343804A
(en)
|
1979-03-26 |
1982-08-10 |
A. H. Robins Company, Inc. |
4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
|
DOP1981004033A
(en)
|
1980-12-23 |
1990-12-29 |
Ciba Geigy Ag |
PROCEDURE TO PROTECT CROP PLANTS FROM PHYTOTOXIC ACTION OF HERBICIDES.
|
US4476248A
(en)
|
1983-02-28 |
1984-10-09 |
The Upjohn Company |
Crystallization of ibuprofen
|
DE3334455A1
(en)
|
1983-03-04 |
1984-09-06 |
Bayer Ag, 5090 Leverkusen |
GUANIDIN DERIVATIVES
|
US4612376A
(en)
|
1983-03-25 |
1986-09-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
|
ZA848275B
(en)
|
1983-12-28 |
1985-08-28 |
Degussa |
New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
|
DE3601196A1
(en)
|
1986-01-17 |
1987-07-23 |
Merck Patent Gmbh |
1,4-DIHYDROPYRIDINE
|
US4810699A
(en)
|
1987-02-20 |
1989-03-07 |
American Home Products Corporation |
Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
|
US4782076A
(en)
|
1988-03-01 |
1988-11-01 |
American Home Products Corporation |
Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, composition and use
|
PT95692A
(en)
|
1989-10-27 |
1991-09-13 |
American Home Prod |
PROCESS FOR THE PREPARATION OF INDOLE-, INDENO-, PYRANOINDOLE- AND TETRA-HYDROCARBAZOLE-ALCANOIC ACID DERIVATIVES, OR WHICH ARE USEFUL AS PLA2 INHIBITORS AND LIPOXIGENASE
|
US5221678A
(en)
|
1990-07-26 |
1993-06-22 |
Merck Frosst Canada, Inc. |
(quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
|
DE4208254A1
(en)
|
1992-03-14 |
1993-09-16 |
Hoechst Ag |
SUBSTITUTED PYRIMIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A PEST CONTROL AND FUNGICIDE
|
FR2692575B1
(en)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
NOVEL PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
|
US5998499A
(en)
|
1994-03-25 |
1999-12-07 |
Dentsply G.M.B.H. |
Liquid crystalline (meth)acrylate compounds, composition and method
|
PL313973A1
(en)
|
1993-10-12 |
1996-08-05 |
Du Pont Merck Pharma |
1 n-alkyl-n-arylopyrimidin amines and their derivatives
|
TW530047B
(en)
|
1994-06-08 |
2003-05-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
US5945426A
(en)
|
1994-09-09 |
1999-08-31 |
Nippon Shinyaku Co., Ltd. |
Derivatives of pyrimidine for treating acute cerebrovascular disorders
|
US5691364A
(en)
|
1995-03-10 |
1997-11-25 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
US6956047B1
(en)
|
1995-06-06 |
2005-10-18 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
KR0169813B1
(en)
|
1995-07-12 |
1999-01-15 |
김종인 |
4-amino-3-acylnaphthyridine derivatives
|
US5849759A
(en)
|
1995-12-08 |
1998-12-15 |
Berlex Laboratories, Inc. |
Naphthyl-substituted benzimidazole derivatives as anti-coagulants
|
US5948786A
(en)
|
1996-04-12 |
1999-09-07 |
Sumitomo Pharmaceuticals Company, Limited |
Piperidinylpyrimidine derivatives
|
US6060478A
(en)
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
US5776967A
(en)
|
1996-07-26 |
1998-07-07 |
American Home Products Corporation |
Pyranoindole inhibitors of COX--2
|
AR008789A1
(en)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
PIRIDINES AND SUBSTITUTED BIPHENYLS
|
US5830911A
(en)
|
1996-08-14 |
1998-11-03 |
American Home Products Corporation |
Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
|
US6008234A
(en)
|
1996-09-12 |
1999-12-28 |
Berlex Laboratories, Inc. |
Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
|
NL1010018C2
(en)
|
1997-09-09 |
1999-03-10 |
Duphar Int Res |
Quinoline and quinazoline derivatives with corticotropin releasing factor (CRF) antagonistic effect.
|
US6861448B2
(en)
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
EP1105394A1
(en)
|
1998-08-21 |
2001-06-13 |
Du Pont Pharmaceuticals Company |
ISOXAZOLO 4,5-d]PYRIMIDINES AS CRF ANTAGONISTS
|
US6239126B1
(en)
|
1998-12-17 |
2001-05-29 |
American Home Products Corporation |
Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives
|
CZ27399A3
(en)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituted nitrogen heterocyclic derivatives process of their preparation, the derivatives employed as medicaments, pharmaceutical composition and a compound pharmaceutical preparation in which these derivatives are comprised as well as use of these derivatives for preparing medicaments
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
EP1177187B1
(en)
|
1999-04-28 |
2007-07-25 |
Sanofi-Aventis Deutschland GmbH |
Di-aryl acid derivatives as ppar receptor ligands
|
EP1195165A4
(en)
|
1999-07-12 |
2005-08-10 |
Ono Pharmaceutical Co |
Fibrosis inhibitors containing as the active ingredient sphingosine-1-phosphate receptor agonist or sphingosine-1-phosphate
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
SK3812002A3
(en)
|
1999-09-17 |
2003-09-11 |
Abbott Gmbh & Co Kg |
Pyrazolopyrimidines as therapeutic agents
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
EA200200424A1
(en)
|
1999-09-30 |
2002-12-26 |
Ньюроджен Корпорейшн |
Some heterocycles substituted by alkylene diamin
|
US6569879B2
(en)
|
2000-02-18 |
2003-05-27 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
US6620821B2
(en)
|
2000-06-15 |
2003-09-16 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
WO2002000216A1
(en)
|
2000-06-28 |
2002-01-03 |
Teva Pharmaceutical Industries Ltd. |
Carvedilol
|
NZ523445A
(en)
|
2000-06-29 |
2004-10-29 |
Abbott Lab |
Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
US20030224058A1
(en)
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
AU2002248221B2
(en)
|
2000-10-31 |
2006-08-17 |
Merck & Co., Inc. |
Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
|
US20020058026A1
(en)
|
2000-11-13 |
2002-05-16 |
Milton Hammerly |
HMG CoA reductase inhibitor medications combined wih CoEnzyme Q-10
|
WO2002039987A2
(en)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
US20020137755A1
(en)
|
2000-12-04 |
2002-09-26 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
US6525064B1
(en)
|
2000-12-08 |
2003-02-25 |
3M Innovative Properties Company |
Sulfonamido substituted imidazopyridines
|
US6545016B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Amide substituted imidazopyridines
|
US6545017B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Urea substituted imidazopyridines
|
ATE331512T1
(en)
|
2001-01-26 |
2006-07-15 |
Schering Corp |
USE OF AZETIDINONE SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF SITOSTEROLHEMIA
|
JP2004529100A
(en)
|
2001-01-30 |
2004-09-24 |
ユニバーシティ オブ バージニア パテント ファウンデーション |
Agonists and antagonists of sphingosine-1-phosphate receptor
|
WO2002079131A1
(en)
|
2001-03-29 |
2002-10-10 |
Kansai Research Institute, Inc. |
Optically active compound and photosensitive resin composition
|
ATE416762T1
(en)
|
2001-05-10 |
2008-12-15 |
Ono Pharmaceutical Co |
CARBOXIC ACID DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THESE AS ACTIVE INGREDIENTS
|
MXPA04002679A
(en)
|
2001-09-27 |
2004-07-30 |
Kyorin Seiyaku Kk |
Diaryl sulfide derivative, addition salt thereof, and immunosuppressant.
|
US20070225351A1
(en)
|
2002-01-11 |
2007-09-27 |
Lippa Arnold S |
Methods and compositions for controlling body weight and appetite
|
US20050239899A1
(en)
|
2002-01-18 |
2005-10-27 |
Wolfgang Fecke |
Beta-secretase inhibitors
|
US7479504B2
(en)
|
2002-01-18 |
2009-01-20 |
Merck & Co., Inc. |
Edg receptor agonists
|
EP1469863A2
(en)
|
2002-01-18 |
2004-10-27 |
Merck & Co., Inc. |
Selective s1p1/edg1 receptor agonists
|
AU2003218056A1
(en)
|
2002-03-01 |
2003-09-16 |
Merck & Co., Inc. |
Aminoalkylphosphonates and related compounds as edg receptor agonists
|
CA2477423A1
(en)
|
2002-03-01 |
2003-09-12 |
Merck & Co., Inc. |
Aminoalkylphosphonates and related compounds as edg receptor agonists
|
DE10219435A1
(en)
|
2002-05-02 |
2003-11-13 |
Bayer Cropscience Ag |
Substituted pyrazolo-pyrimidin-4-ones
|
US7057046B2
(en)
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
US7763278B2
(en)
|
2002-06-10 |
2010-07-27 |
Elan Pharma International Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
CA2488117A1
(en)
|
2002-06-17 |
2003-12-24 |
Merck & Co., Inc. |
1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
|
JPWO2004007472A1
(en)
|
2002-07-10 |
2005-11-17 |
小野薬品工業株式会社 |
CCR4 antagonist and pharmaceutical use thereof
|
EP1546110A4
(en)
|
2002-07-30 |
2008-03-26 |
Univ Virginia |
Compounds active in sphingosine 1-phosphate signaling
|
DE10237722A1
(en)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indole or benzimidazole derivatives for the modulation of IKappaB kinase
|
AU2003277576A1
(en)
|
2002-11-08 |
2004-06-07 |
Takeda Pharmaceutical Company Limited |
Receptor function controlling agent
|
US7098235B2
(en)
|
2002-11-14 |
2006-08-29 |
Bristol-Myers Squibb Co. |
Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
|
US20040110241A1
(en)
|
2002-12-06 |
2004-06-10 |
Segal Mark S. |
Materials and methods for monitoring vascular endothelial function
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Triazole Derivatives As Inhibitors Of 11-Beta -Hydroxysteriod Dehydrogenase-1
|
AU2003297232B2
(en)
|
2002-12-20 |
2010-02-04 |
Merck Sharp & Dohme Corp. |
1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles
|
DK1599468T3
(en)
|
2003-01-14 |
2008-02-04 |
Arena Pharm Inc |
1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prevention and treatment of disorders associated therewith such as diabetes and hyperglycemia
|
GB0301259D0
(en)
|
2003-01-20 |
2003-02-19 |
Novartis Ag |
Organic compounds
|
AU2004210697B2
(en)
|
2003-02-11 |
2007-10-18 |
Irm Llc |
Novel bicyclic compounds and compositions
|
KR101005171B1
(en)
|
2003-02-18 |
2011-01-04 |
교린 세이야꾸 가부시키 가이샤 |
Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators
|
CN1751038A
(en)
|
2003-02-24 |
2006-03-22 |
艾尼纳制药公司 |
Substituted aryl and heteroaryl derivatives as modulators of glucose metabolism and the prophylaxis and treatment of disorders thereof
|
MXPA05011539A
(en)
|
2003-04-30 |
2006-01-23 |
Inst For Pharm Discovery Inc |
Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b.
|
CA2523677A1
(en)
|
2003-04-30 |
2004-11-11 |
Novartis Ag |
Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
|
ES2383298T3
(en)
|
2003-04-30 |
2012-06-20 |
Novartis Ag |
Amino-propanol derivatives as sphingosine-1-phosphate receptor modulators
|
US7083933B1
(en)
|
2003-05-09 |
2006-08-01 |
Prosidion Limited |
Methods for identification of modulators of OSGPR116 activity
|
US20060252741A1
(en)
|
2003-05-15 |
2006-11-09 |
Colandrea Vincent J |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
WO2004104205A2
(en)
*
|
2003-05-16 |
2004-12-02 |
Merck & Co., Inc. |
Enzymatic preparation of chiral indole esters
|
EP1638551B1
(en)
|
2003-05-19 |
2011-12-21 |
Irm Llc |
Immunosuppressant compounds and compositions
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
JP4728962B2
(en)
|
2003-05-19 |
2011-07-20 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Immunosuppressive compounds and compositions
|
CA2524048C
(en)
|
2003-05-19 |
2013-06-25 |
Irm Llc |
Immunosuppressant compounds and compositions
|
GB0313612D0
(en)
|
2003-06-12 |
2003-07-16 |
Novartis Ag |
Organic compounds
|
AR045047A1
(en)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
ARILO AND HETEROARILO DERIVATIVES TRISUSTITUIDOS AS MODULATORS OF METABOLISM AND PROFILAXIS AND TREATMENT OF DISORDERS RELATED TO THEMSELVES
|
EP2287166A3
(en)
|
2003-07-14 |
2011-06-22 |
Arena Pharmaceuticals, Inc. |
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
|
JPWO2005012221A1
(en)
|
2003-08-04 |
2006-09-14 |
小野薬品工業株式会社 |
Diphenyl ether compound, its production method and use
|
WO2005021503A1
(en)
|
2003-08-28 |
2005-03-10 |
Novartis Ag |
Aminopropanol derivatives
|
CN101407471A
(en)
|
2003-08-29 |
2009-04-15 |
小野药品工业株式会社 |
Compound capable of binding S1P receptor and pharmaceutical use thereof
|
WO2005023771A1
(en)
|
2003-09-05 |
2005-03-17 |
Ono Pharmaceutical Co., Ltd. |
Chemokine receptor antagonist and medical use thereof
|
CN1859908A
(en)
*
|
2003-10-01 |
2006-11-08 |
默克公司 |
3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as S1P receptor agonists
|
US7638637B2
(en)
|
2003-11-03 |
2009-12-29 |
University Of Virginia Patent Foundation |
Orally available sphingosine 1-phosphate receptor agonists and antagonists
|
WO2005044780A1
(en)
|
2003-11-10 |
2005-05-19 |
Kyorin Pharmaceutical Co., Ltd. |
Aminocarboxylic acid derivative, addition salt thereof, and s1p receptor control agent
|
JP4773972B2
(en)
|
2003-12-17 |
2011-09-14 |
メルク・シャープ・エンド・ドーム・コーポレイション |
(3,4-Disubstituted) propanecarboxylic acids as S1P (Edg) receptor agonists
|
GB0329498D0
(en)
|
2003-12-19 |
2004-01-28 |
Novartis Ag |
Organic compounds
|
JP4766384B2
(en)
|
2003-12-19 |
2011-09-07 |
小野薬品工業株式会社 |
Compound having lysophosphatidic acid receptor antagonistic activity and use thereof
|
GB0401332D0
(en)
*
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
US7534798B2
(en)
|
2004-02-11 |
2009-05-19 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
JP4740884B2
(en)
|
2004-02-24 |
2011-08-03 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Immunosuppressive compounds and compositions
|
KR20110136901A
(en)
|
2004-02-24 |
2011-12-21 |
상꾜 가부시키가이샤 |
Amino alcohol compound
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
AU2005219791B2
(en)
|
2004-03-05 |
2011-06-09 |
Msd K.K. |
Diaryl-substituted five-membered heterocycle derivative
|
GB0405289D0
(en)
|
2004-03-09 |
2004-04-21 |
Novartis Ag |
Organic compounds
|
JP5239071B2
(en)
|
2004-04-02 |
2013-07-17 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Asymmetric hydrogenation methods useful for the preparation of cycloalkanoindole derivatives
|
DK1756084T3
(en)
|
2004-06-04 |
2009-03-23 |
Arena Pharm Inc |
Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prevention and treatment of disorders related thereto
|
WO2005123677A1
(en)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
EP1760071A4
(en)
|
2004-06-23 |
2008-03-05 |
Ono Pharmaceutical Co |
Compound having s1p receptor binding potency and use thereof
|
PL1772145T3
(en)
|
2004-07-16 |
2011-08-31 |
Kyorin Seiyaku Kk |
Method of effectively using medicine and method concerning prevention of side effect
|
JP2007284350A
(en)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
Therapeutic agent for diabetes
|
TW200611687A
(en)
|
2004-07-29 |
2006-04-16 |
Sankyo Co |
Pharmaceutical compositions used for immunosuppressant
|
WO2006010379A1
(en)
|
2004-07-29 |
2006-02-02 |
Actelion Pharmaceuticals Ltd. |
Novel thiophene derivatives as immunosuppressive agents
|
CN1993333B
(en)
|
2004-08-04 |
2012-08-01 |
大正制药株式会社 |
Triazole derivative
|
US20060223866A1
(en)
|
2004-08-13 |
2006-10-05 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
|
WO2006020951A1
(en)
|
2004-08-13 |
2006-02-23 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
|
US7250441B2
(en)
|
2004-09-23 |
2007-07-31 |
Wyeth |
Carbazole and cyclopentaindole derivatives to treat infection with Hepatitis C virus
|
MX2007004262A
(en)
|
2004-10-12 |
2008-03-04 |
Forbes Medi Tech Res Inc |
Compounds and methods of treating insulin resistance and cardiomyopathy.
|
DK1650186T3
(en)
|
2004-10-22 |
2008-10-13 |
Sun Pharmaceutical Ind Ltd |
New dicarboxylic acid derivatives
|
WO2006047195A2
(en)
|
2004-10-22 |
2006-05-04 |
Merck & Co., Inc. |
2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists
|
JP2008520692A
(en)
|
2004-11-18 |
2008-06-19 |
ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー |
Heterocyclic substituted carboxylic acids
|
WO2006057448A1
(en)
|
2004-11-26 |
2006-06-01 |
Takeda Pharmaceutical Company Limited |
Arylalkanoic acid derivative
|
WO2006063033A2
(en)
|
2004-12-06 |
2006-06-15 |
University Of Virginia Patent Foundation |
Aryl amide sphingosine 1-phosphate analogs
|
PL1826197T3
(en)
|
2004-12-13 |
2012-06-29 |
Ono Pharmaceutical Co |
Aminocarboxylic acid derivative and medicinal use thereof
|
WO2006064744A1
(en)
|
2004-12-13 |
2006-06-22 |
Daiichi Sankyo Company, Limited |
Medicinal composition for treating diabetes
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
DOP2006000010A
(en)
|
2005-01-10 |
2006-07-31 |
Arena Pharm Inc |
PROCEDURE TO PREPARE AROMATIC ETERES
|
DOP2006000008A
(en)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED AFFECTIONS AND FOR THE TREATMENT OF AFFECTIONS THAT IMPROVE THROUGH AN INCREASE IN THE BLOOD CONCENTRATION OF GLP-1
|
DOP2006000009A
(en)
|
2005-01-13 |
2006-08-15 |
Arena Pharm Inc |
PROCEDURE TO PREPARE ETERES OF PIRAZOLO [3,4-D] PYRIMIDINE
|
JP5798282B2
(en)
|
2005-01-25 |
2015-10-21 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
Mesogenic compound, liquid crystal medium and liquid crystal display
|
EP1685841A1
(en)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prevention and treatment of thromboembolic disorders
|
MX2007009848A
(en)
|
2005-02-14 |
2008-03-10 |
Univ Virginia |
Sphingosine 1- phos phate agonists comprising cycloalkanes and 5 -membered heterocycles substituted by amino and phenyl groups.
|
JP5047941B2
(en)
|
2005-03-23 |
2012-10-10 |
アクテリオン ファーマシューティカルズ リミテッド |
Hydrogenated benzo (C) thiophene derivatives as immunomodulators
|
RU2404178C2
(en)
|
2005-03-23 |
2010-11-20 |
Актелион Фармасьютиклз Лтд |
Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
|
CN101180050B
(en)
|
2005-03-23 |
2011-07-27 |
埃科特莱茵药品有限公司 |
Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
|
AU2006256968A1
(en)
|
2005-06-08 |
2006-12-14 |
Novartis Ag |
Polycyclic oxadiazoles or I soxazoles and their use as SIP receptor ligands
|
TWI418350B
(en)
|
2005-06-24 |
2013-12-11 |
Sankyo Co |
Use of pharmaceutical compositions comprising ppar modulator
|
AU2006260573A1
(en)
|
2005-06-24 |
2006-12-28 |
Actelion Pharmaceuticals Ltd. |
Novel thiophene derivatives
|
MX2007016545A
(en)
|
2005-06-30 |
2008-02-21 |
Prosidion Ltd |
G-protein coupled receptor agonists.
|
US20070060573A1
(en)
|
2005-08-10 |
2007-03-15 |
Lars Wortmann |
Acyltryptophanols
|
AU2006283175A1
(en)
|
2005-08-23 |
2007-03-01 |
Irm Llc |
Immunosuppressant compounds and compositions
|
CN101263135A
(en)
|
2005-09-16 |
2008-09-10 |
艾尼纳制药公司 |
Modulators of metabolism and the treatment of disorders related thereto
|
WO2007037196A1
(en)
|
2005-09-29 |
2007-04-05 |
Yamamoto Chemicals, Inc. |
Indoline compound and method for producing same
|
PT1932522E
(en)
|
2005-10-07 |
2012-06-26 |
Kyorin Seiyaku Kk |
Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient
|
AU2006317689B2
(en)
|
2005-11-23 |
2013-07-25 |
Epix Delaware, Inc. |
S1P receptor modulating compounds and use thereof
|
AR057894A1
(en)
|
2005-11-23 |
2007-12-26 |
Actelion Pharmaceuticals Ltd |
THIOPHEN DERIVATIVES
|
TWI404706B
(en)
|
2006-01-11 |
2013-08-11 |
Actelion Pharmaceuticals Ltd |
Novel thiophene derivatives
|
TW200736234A
(en)
|
2006-01-17 |
2007-10-01 |
Astrazeneca Ab |
Chemical compounds
|
ES2600804T3
(en)
|
2006-01-19 |
2017-02-10 |
Orchid Pharma Limited |
New heterocycles
|
EP1979345B1
(en)
|
2006-01-24 |
2009-11-04 |
Actelion Pharmaceuticals Ltd. |
Novel pyridine derivatives
|
GB0601744D0
(en)
|
2006-01-27 |
2006-03-08 |
Novartis Ag |
Organic compounds
|
TWI389683B
(en)
|
2006-02-06 |
2013-03-21 |
Kyorin Seiyaku Kk |
A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
|
TW200806611A
(en)
|
2006-02-09 |
2008-02-01 |
Daiichi Seiyaku Co |
Novel amidopropionic acid derivatives and medicine containing the same
|
CA2641718A1
(en)
|
2006-02-09 |
2007-08-16 |
University Of Virginia Patent Foundation |
Bicyclic sphingosine 1-phosphate analogs
|
US20070191371A1
(en)
|
2006-02-14 |
2007-08-16 |
Kalypsys, Inc. |
Heterocyclic modulators of ppar
|
CN101460458A
(en)
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
WO2007095561A2
(en)
|
2006-02-15 |
2007-08-23 |
Allergan, Inc. |
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
|
EP1991535A1
(en)
|
2006-02-21 |
2008-11-19 |
University Of Virginia Patent Foundation |
Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as sip receptor agonists
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
CA2646430A1
(en)
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
|
CA2646469A1
(en)
|
2006-03-21 |
2007-09-27 |
Epix Delaware, Inc. |
S1p receptor modulating compounds
|
JP2007262009A
(en)
|
2006-03-29 |
2007-10-11 |
Dai Ichi Seiyaku Co Ltd |
Heteroaryl lower carboxylic acid derivative
|
ES2453372T3
(en)
|
2006-04-03 |
2014-04-07 |
Astellas Pharma Inc. |
Oxadiazole derivatives as S1P1 agonists
|
GB0607389D0
(en)
|
2006-04-12 |
2006-05-24 |
Novartis Ag |
Organic compounds
|
WO2007129473A1
(en)
|
2006-05-09 |
2007-11-15 |
Daiichi Sankyo Company, Limited |
Bicyclic aryl derivative
|
US20090324581A1
(en)
|
2006-05-09 |
2009-12-31 |
Daiichi Sankyo Company Limited |
Heteroarylamide lower carboxylic acid derivative
|
WO2007132307A1
(en)
|
2006-05-09 |
2007-11-22 |
Pfizer Products Inc. |
Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
JP2009545597A
(en)
|
2006-08-01 |
2009-12-24 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
Sphingosine-1-phosphate receptor (SLP) agonist
|
AR062156A1
(en)
|
2006-08-01 |
2008-10-22 |
Praecis Pharm Inc |
S1P-1 RECEPTOR AGONIST AND SELECTIVE COMPOUNDS
|
JP2009545630A
(en)
|
2006-08-04 |
2009-12-24 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
Compound
|
NZ574011A
(en)
|
2006-08-08 |
2011-10-28 |
Kyorin Seiyaku Kk |
Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient
|
WO2008024196A1
(en)
|
2006-08-24 |
2008-02-28 |
Praecis Pharmaceuticals Incorporated |
Chemical compounds
|
JP2009269819A
(en)
|
2006-08-25 |
2009-11-19 |
Asahi Kasei Pharma Kk |
Amine compound
|
AR061841A1
(en)
|
2006-09-07 |
2008-09-24 |
Actelion Pharmaceuticals Ltd |
DERIVATIVES OF THIOFEN-OXADIAZOLS, AGONISTS OF THE S1P1 / EDG1 RECEPTOR, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES AS IMMUNOMODULATING AGENTS.
|
BRPI0716815A2
(en)
|
2006-09-07 |
2013-11-05 |
Allergan Inc |
HETEROATOMATIC POST HAVING AGONIST AND / OR ANTAGONIST BIOLOGICAL ACTIVITY OF SPINPHOSINE-1-PHOSPHATE (S1P) RECEIVER
|
AU2007292993B2
(en)
|
2006-09-07 |
2013-01-24 |
Idorsia Pharmaceuticals Ltd |
Pyridin-4-yl derivatives as immunomodulating agents
|
CN101511783A
(en)
|
2006-09-08 |
2009-08-19 |
诺瓦提斯公司 |
N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
|
RU2442780C2
(en)
|
2006-09-21 |
2012-02-20 |
Актелион Фармасьютиклз Лтд |
Phenyl derivatives and their application as immunomodulators
|
CN101657471B
(en)
|
2006-12-06 |
2013-07-03 |
史密丝克莱恩比彻姆公司 |
Bicyclic compounds and use as antidiabetics
|
AU2007334436A1
(en)
|
2006-12-15 |
2008-06-26 |
Abbott Laboratories |
Novel oxadiazole compounds
|
GB0625648D0
(en)
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
JO2701B1
(en)
|
2006-12-21 |
2013-03-03 |
جلاكسو جروب ليميتد |
Compounds
|
GB0625647D0
(en)
*
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
TW200838497A
(en)
|
2006-12-21 |
2008-10-01 |
Abbott Lab |
Sphingosine-1-phosphate receptor agonist and antagonist compounds
|
KR20090101307A
(en)
|
2007-01-11 |
2009-09-24 |
알러간, 인코포레이티드 |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
|
WO2008091967A1
(en)
|
2007-01-26 |
2008-07-31 |
Smithkline Beecham Corporation |
Chemical compounds
|
WO2008097819A2
(en)
|
2007-02-05 |
2008-08-14 |
Smithkline Beecham Corporation |
Chemical compounds
|
DK2125797T3
(en)
|
2007-03-16 |
2014-02-10 |
Actelion Pharmaceuticals Ltd |
AMINOPYRIDINE DERIVATIVES AS S1P1 / EDG1 RECEPTOR AGONISTS
|
EP2121648A2
(en)
|
2007-03-21 |
2009-11-25 |
EPIX Pharmaceuticals, Inc. |
S1p receptor modulating compounds and use thereof
|
KR20090130062A
(en)
|
2007-04-19 |
2009-12-17 |
글락소 그룹 리미티드 |
Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
|
EP2014653A1
(en)
|
2007-06-15 |
2009-01-14 |
Bioprojet |
Novel dicarboxylic acid derivatives as S1P1 receptor agonists
|
US20090069288A1
(en)
|
2007-07-16 |
2009-03-12 |
Breinlinger Eric C |
Novel therapeutic compounds
|
WO2009019506A1
(en)
|
2007-08-03 |
2009-02-12 |
Astrazeneca Ab |
Heterocyclyc sulfonamides having edg-1 antagonistic activity
|
JP5508265B2
(en)
|
2007-08-08 |
2014-05-28 |
メルク セローノ ソシエテ アノニム |
6-amino-pyrimidine-4-carboxamide derivatives and related compounds that bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis
|
BRPI0817211A2
(en)
|
2007-09-20 |
2017-05-16 |
Irm Llc |
compound compositions as modulators of gpr119 activity
|
TW200930368A
(en)
|
2007-11-15 |
2009-07-16 |
Astrazeneca Ab |
Bis-(sulfonylamino) derivatives in therapy
|
US8637704B2
(en)
|
2007-11-28 |
2014-01-28 |
Synta Pharmaceuticals Corp. |
Polymorphs of N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide)
|
EP2222668B1
(en)
|
2007-12-18 |
2011-11-02 |
Arena Pharmaceuticals, Inc. |
Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
|
AU2009206733A1
(en)
|
2008-01-25 |
2009-07-30 |
Arena Pharmaceuticals, Inc. |
Dihydro- 1H- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as S1P1 agonists
|
AR070398A1
(en)
|
2008-02-22 |
2010-03-31 |
Gruenenthal Chemie |
INDOL SUBSTITUTED DERIVATIVES
|
EP2258040A2
(en)
|
2008-02-28 |
2010-12-08 |
Solar Roofing Systems, Inc. |
Photovoltaic roofing tile with fire suppression
|
WO2009115954A1
(en)
|
2008-03-17 |
2009-09-24 |
Actelion Pharmaceuticals Ltd |
Dosing regimen for a selective s1p1 receptor agonist
|
NZ589617A
(en)
|
2008-05-14 |
2012-06-29 |
Scripps Research Inst |
3-(Inden-4-yl)-5-(phenyl)-1,2,4-oxadiazole and 3-(tetralin-5-yl)-5-(phenyl)-1,2,4-oxadiazole derivatives
|
WO2009151621A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
WO2009151626A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
HUE030424T2
(en)
|
2008-07-23 |
2017-05-29 |
Arena Pharm Inc |
SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
|
SI2342205T1
(en)
|
2008-08-27 |
2016-09-30 |
Arena Pharmaceuticals, Inc. |
Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
|
SI3409274T1
(en)
|
2008-12-22 |
2020-03-31 |
Novartis Ag |
Dosage regimen for a s1p receptor agonist
|
PL2379069T3
(en)
|
2008-12-22 |
2015-08-31 |
Novartis Ag |
Dosage regimen of an s1p receptor agonist
|
CA2749960A1
(en)
|
2009-02-10 |
2010-08-19 |
Abbott Laboratories |
Agonists and antagonists of the s1p5 receptor, and methods of uses thereof
|
WO2011005290A1
(en)
|
2009-06-23 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders
|
WO2011005295A1
(en)
|
2009-06-24 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
|
EP2597089A1
(en)
|
2009-10-29 |
2013-05-29 |
Bristol-Myers Squibb Company |
Tricyclic heterocyclic compounds
|
US8299059B2
(en)
|
2009-10-30 |
2012-10-30 |
Eli Lilly And Company |
Crystalline compound and a process for its preparation
|
US8440693B2
(en)
|
2009-12-22 |
2013-05-14 |
Novartis Ag |
Substituted isoquinolinones and quinazolinones
|
EP2470529B1
(en)
|
2009-12-30 |
2014-11-19 |
Medichem, S.A. |
A 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivate with substantially undefined crystal shape for preparing said 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative
|
ES2937386T3
(en)
|
2010-01-27 |
2023-03-28 |
Arena Pharm Inc |
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts of same
|
WO2011109471A1
(en)
|
2010-03-03 |
2011-09-09 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
|
BR112012025592A2
(en)
|
2010-04-06 |
2019-09-24 |
Arena Pharm Inc |
gpr119 receptor modulators and the treatment of disorders related thereto
|
WO2012015758A2
(en)
|
2010-07-30 |
2012-02-02 |
Saint Louis University |
Methods of treating pain
|
SG188548A1
(en)
|
2010-09-22 |
2013-04-30 |
Arena Pharm Inc |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
BR112013019683B1
(en)
|
2011-02-07 |
2022-04-19 |
Biogen Inc |
Compounds that modulate s1p, pharmaceutical composition, and use thereof
|
US20140038889A1
(en)
|
2011-04-22 |
2014-02-06 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
BR112014018485A8
(en)
|
2012-02-03 |
2017-07-11 |
Teva Pharma |
USE OF LAQUINIMOD TO TREAT PATIENTS WITH CROHN'S DISEASE WHO HAVE FAILED FIRST LINE ANTI-TNF THERAPY
|
US20160038506A1
(en)
|
2012-02-14 |
2016-02-11 |
Repros Therapeutics Inc. |
Selective Estrogen Receptor Modulators With Short Half-Lives and Uses Thereof
|
US8962888B2
(en)
|
2012-12-03 |
2015-02-24 |
Physical Sciences, Inc. |
Forming spherical crystal habit
|
JP5589110B1
(en)
|
2013-03-08 |
2014-09-10 |
株式会社ポーラファルマ |
Crystal having crystal habit and pharmaceutical composition containing the crystal as an active ingredient
|
EP3242666A1
(en)
|
2015-01-06 |
2017-11-15 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|
JP6838744B2
(en)
|
2015-06-22 |
2021-03-03 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
(R) -2- (7- (4-cyclopentyl-3- (trifluoromethyl) benzyloxy) -1,2,3,4-tetrahydrocyclopenta [b] indole-for use in S1P1 receptor-related disorders Crystalline L-arginine salt of 3-yl) acetic acid (Compound 1)
|
KR20190116416A
(en)
|
2017-02-16 |
2019-10-14 |
아레나 파마슈티칼스, 인크. |
Compounds and Methods for Treating Primary Bile Cholangitis
|
CN110545848A
(en)
|
2017-02-16 |
2019-12-06 |
艾尼纳制药公司 |
Compounds and methods for treating inflammatory bowel disease with extra-intestinal manifestations
|
KR20210029190A
(en)
|
2018-06-06 |
2021-03-15 |
아레나 파마슈티칼스, 인크. |
Methods of treating conditions related to the S1P1 receptor
|
US20210386706A1
(en)
|
2018-10-03 |
2021-12-16 |
Arena Pharmaceuticals, Inc. |
Methods for the treatment of scleroderma
|
AU2019387212A1
(en)
|
2018-11-30 |
2021-06-24 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
US20220142977A1
(en)
|
2019-01-08 |
2022-05-12 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|